CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
摘要
无
机构地区
Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230031, China,Department of Hematology, The First Affiliated Hospital of USCT, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China,PersonGen-Anke
出版日期
2022年12月13日(中国期刊网平台首次上网日期,不代表论文的发表时间)